
A recent study delved into the correlation between sclerostin and pulmonary hypertension (PH) in patients with stage 5 chronic kidney disease (CKD) before dialysis. Elevated levels of sclerostin (≥218.18pmol/L) were linked to cardiac abnormalities, particularly PH. Statistical analyses revealed a significant association between sclerostin levels exceeding 218.19pmol/L and PH, underscoring its potential as a prognostic marker. Additionally, systemic vascular calcification score and PH emerged as risk factors for heightened all-cause mortality in this patient group. These findings illuminate the interplay between serum sclerostin, PH, and mortality risk among pre-dialysis CKD patients.
Like
Save
Share